Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

The author felt excited and honored to receive the 2016 Early Career Life Scientist Award.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Early NAS level changes affect alcohol consumption vulnerability.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Women with PCOS tend to be less optimistic than those without it.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Women with PCOS have more emotional and body image issues than healthy women.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Women with PCOS often experience anxiety, depression, and a lower quality of life.